Last updated: July 2026
The Roundup lawsuit claims the weedkiller’s active ingredient, glyphosate, causes non-Hodgkin lymphoma. In February 2026, Bayer proposed a $7.25 billion class settlement covering current and future claimants. Published payout estimates range from about $10,000 to $165,000 per person, depending on exposure, age at diagnosis, and cancer type. Final court approval is still pending.
A lot has changed in 2026. The Supreme Court issued a major ruling in June, and a final approval hearing on the settlement took place on July 9, 2026. This guide covers where the litigation stands, who qualifies, and what a claim might pay.
What Is the Roundup Lawsuit About?
Roundup is the best-selling weedkiller in US history. Farmers, landscapers, groundskeepers, and home gardeners have sprayed it for decades. Monsanto developed the product, and Bayer took on the litigation when it bought Monsanto in 2018.
Plaintiffs say glyphosate exposure caused their non-Hodgkin lymphoma (NHL) and that the company never warned them of the risk. The science is contested. In 2015, the World Health Organization’s cancer research agency classified glyphosate as probably carcinogenic to humans. The Environmental Protection Agency has taken the opposite view, finding glyphosate is not likely to cause cancer when used as directed.
Juries have often sided with injured users anyway. Bayer has faced roughly 181,000 US claims and has already paid out around $11 billion to resolve most of them. When the new settlement was announced, roughly 61,000 to 67,000 claims were still pending, including about 4,000 in a consolidated federal proceeding in California. [VERIFY current case counts]
What Did the Supreme Court Decide in June 2026?
On June 25, 2026, the Supreme Court decided Monsanto v. Durnell. The Court held that the federal pesticide statute, FIFRA, preempts state law failure-to-warn claims. In plain English: because the EPA approved Roundup’s label without a cancer warning, plaintiffs can no longer win by arguing that state law required one.
That matters because failure to warn was the central theory in almost every Roundup case, including the biggest verdicts. The ruling wiped out Mr. Durnell’s $1.25 million Missouri award. It does not claw back money already paid in past settlements, and claims built on other theories, such as design defect, may still be pursued. [VERIFY how lower courts apply the ruling to pending cases]
The practical effect is pressure. With trials now much harder for plaintiffs to win, the proposed class settlement has become the main path to compensation.
How Much Is the Roundup Settlement Worth?
On February 17, 2026, Bayer announced a proposed $7.25 billion nationwide settlement, filed in Missouri state court in St. Louis. It is built to resolve current claims and future ones, covering people diagnosed with NHL for years after approval.
The timeline so far: preliminary approval came in March 2026, the opt-out deadline passed in early June 2026 [VERIFY], and the final approval hearing was held on July 9, 2026. A final ruling had not been published when this article was last updated. [VERIFY approval status]
Payouts follow a point system. Points depend on how you were exposed, for how long, your age at diagnosis, and how aggressive your NHL is. More points mean a larger payment.
| Claimant profile | Reported payout estimate |
|---|---|
| Occupational users (farming, landscaping, groundskeeping) with long-term exposure and aggressive NHL diagnosed before age 60 | Up to about $165,000 |
| Occupational users generally | About $85,000-$165,000 |
| Residential users with qualifying exposure | About $20,000-$40,000 |
| Claimants diagnosed at age 78 or older | About $10,000 |
These figures come from published reports on the proposed deal and could shift before checks go out. [VERIFY final payout grid] Attorney fees, usually 33 to 40 percent on contingency, plus case costs, come out of the gross amount.
For context, Bayer’s 2020 settlement round paid about $10.9 billion across roughly 100,000 claims. That averages out near $110,000 per claim before fees, though individual results varied widely based on case strength.
Who Qualifies for a Roundup Lawsuit Settlement?
Eligibility comes down to two things: a qualifying diagnosis and real exposure to Roundup. Here is what claim reviewers look for.
- Diagnosis: non-Hodgkin lymphoma or one of its subtypes, such as diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, or marginal zone lymphoma.
- Exposure: meaningful use of Roundup before diagnosis. Reports on the class settlement describe a threshold of roughly 120 hours of use over at least two years. [VERIFY exact class definition]
- Timing: your claim must fit within your state’s statute of limitations, often one to three years from diagnosis or from when you connected the illness to Roundup.
- Documentation: medical records confirming NHL, plus proof of use such as receipts, photos, employment records, or witness statements.
Occupational users, such as farm workers, landscapers, and groundskeepers, tend to hold the strongest claims because their exposure was heavy and repeated. Family members may also bring a wrongful death claim if a loved one died of NHL after significant Roundup use.
What Have Juries Awarded in Roundup Trials?
Jury verdicts made headlines for years, but most were sharply reduced after trial. They also never predicted what a typical settlement pays. Here are the landmark results.
| Case | Year | Jury award | Outcome |
|---|---|---|---|
| Johnson v. Monsanto (California) | 2018 | $289 million | Reduced to $20.5 million |
| Hardeman v. Monsanto (federal) | 2019 | $80 million | Reduced to about $25 million |
| Pilliod v. Monsanto (California) | 2019 | $2 billion | Reduced to about $87 million |
| Durnell v. Monsanto (Missouri) | 2023 | $1.25 million | Overturned by the Supreme Court, June 2026 |
| McKivison v. Monsanto (Philadelphia) | 2024 | $2.25 billion | Reduced to about $400 million |
| Barnes v. Monsanto (Georgia) | 2025 | $2.065 billion | On appeal [VERIFY] |
After Durnell, verdicts like these are unlikely to be repeated, since the legal theory behind them is now preempted.
How Do You File a Roundup Claim?
- Confirm your diagnosis. Request complete medical records showing your NHL subtype, diagnosis date, and treatment history.
- Document your exposure. Gather receipts, product photos, employment records, pesticide application logs, and witness statements.
- Talk to a mass tort attorney. Consultations are free, and these cases run on contingency, so you pay nothing upfront.
- Choose your path. If the settlement wins final approval, most claimants will go through its claims process rather than through a trial.
- Watch your deadlines. State statutes of limitations still apply, often one to three years from diagnosis or discovery of the link.
The Bottom Line
The Roundup lawsuit has entered its endgame. The Supreme Court closed the courthouse door on the main legal theory, and Bayer’s $7.25 billion settlement is now the realistic route to compensation for most people. If you or a family member developed non-Hodgkin lymphoma after regular Roundup use, gather your records and talk to a lawyer now rather than later.
Frequently Asked Questions
Is it too late to file a Roundup lawsuit in 2026?
Not necessarily. The proposed class settlement is designed to cover people diagnosed with non-Hodgkin lymphoma in the future, and state filing deadlines often run one to three years from diagnosis. However, the Supreme Court’s June 2026 ruling makes new individual trials much harder to win. Talk to an attorney quickly to protect your options.
How much is the average Roundup settlement per person?
Bayer’s 2020 settlement round paid about $10.9 billion across roughly 100,000 claims, an average near $110,000 before attorney fees. Under the proposed 2026 class settlement, published estimates range from about $10,000 for lower-tier claims to about $165,000 for long-term occupational users diagnosed with aggressive non-Hodgkin lymphoma before age 60.
Which cancers qualify for a Roundup claim?
Non-Hodgkin lymphoma and its subtypes are the qualifying diagnoses. These include diffuse large B-cell lymphoma, follicular lymphoma, marginal zone lymphoma, mantle cell lymphoma, chronic lymphocytic leukemia, and small lymphocytic lymphoma. Other cancers, such as multiple myeloma or leukemias unrelated to NHL, generally have not qualified for Roundup compensation.
Did the Supreme Court end Roundup lawsuits?
Not completely. In Monsanto v. Durnell, decided June 25, 2026, the Court ruled that federal pesticide law blocks state failure-to-warn claims, the main theory in most Roundup cases. The $7.25 billion class settlement still moves forward, past settlements are not affected, and claims based on other legal theories may continue.
Do I need a lawyer to get a Roundup settlement?
You are not required to hire one, but it usually helps. Roundup lawyers work on contingency, typically 33 to 40 percent of your recovery, with free consultations. The settlement’s point system rewards strong documentation of exposure and diagnosis, and an experienced attorney knows how to build that record and meet every deadline.
Disclaimer: This article is general information, not legal advice. Laws, deadlines, and settlement terms change, and every case is different. Speak with a licensed attorney in your state about your specific situation.